parthenolide has been researched along with cyclin d1 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Crooks, PA; Nakshatri, H; Neelakantan, S; Noble, S; Ralstin, M; Schmidt, CM; Sweeney, CJ; Wu, H; Yiannoutsos, C; Yip-Schneider, MT | 1 |
Cheng, G; Xie, L | 1 |
Bai, S; Lu, J; Sheng, G; Wang, C; Wang, L; Wang, Y | 1 |
Aviles-Vazquez, S; Ayala-Sanchez, M; Chávez-González, A; Crooks, PA; Flores-Lopez, G; Guzman, ML; Mayani, H; Moreno-Lorenzana, D; Torres-Martinez, H | 1 |
Cao, Y; Li, Y; Liu, D; Liu, M; Yang, Y | 1 |
Cui, Q; Gu, W; Li, D; Li, Y; Pan, Z; Tan, X; Wang, X; Wu, S; Xu, H; Yang, L | 1 |
6 other study(ies) available for parthenolide and cyclin d1
Article | Year |
---|---|
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclin D1; Humans; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Prostaglandin-Endoperoxide Synthases; Sesquiterpenes; Sulindac | 2007 |
Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 2; Diffusion Chambers, Culture; Flow Cytometry; G1 Phase; Humans; Microscopy; Neoplasm Invasiveness; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Signal Transduction; Tanacetum parthenium; Urinary Bladder Neoplasms | 2011 |
Combined effects of FLT3 and NF-κB selective inhibitors on acute myeloid leukemia in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Line, Tumor; Cyclin D1; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Nuclear Receptor Co-Repressor 2; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Thiophenes; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction | 2018 |
Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin D1; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Stomach Neoplasms | 2020 |
Parthenolide inhibits proliferation of cells infected with Kaposi's sarcoma-associated herpesvirus by suppression of the NF-κB signaling pathway.
Topics: Cell Proliferation; Cyclin D1; Herpesvirus 8, Human; Humans; I-kappa B Kinase; Neuroblastoma; NF-kappa B; RNA, Messenger; Sarcoma, Kaposi; Signal Transduction | 2023 |